Alpha Wave Global

Alpha Wave Global is a diversified global alternative asset manager and investment firm founded in 2012. The company focuses on private equity, private credit, and public markets investments across multiple sectors including information technology, fintech, AI, and life sciences. It manages over $10 billion in assets with more than 200 portfolio companies worldwide. While not directly involved in drug development or clinical research itself, Alpha Wave has led or participated in major funding rounds for innovative biotech and healthcare companies such as Life Biosciences (aging therapeutics), Human Immunology Biosciences (immune-mediated diseases), Moonwalk Biosciences (epigenetic medicines), and COUR Pharmaceuticals (immune tolerance therapies).